Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market

被引:70
|
作者
Norman, Caitlyn [1 ]
Walker, Gillian [2 ]
McKirdy, Brian [2 ]
McDonald, Ciara [1 ,3 ]
Fletcher, Daniel [4 ]
Antonides, Lysbeth H. [1 ,5 ]
Sutcliffe, Oliver B. [6 ]
Daeid, Niamh Nic [1 ,5 ]
McKenzie, Craig [1 ]
机构
[1] Univ Dundee, Forens Drug Res Grp, Ctr Anat & Human Identificat, Sch Sci & Engn, Dundee, Scotland
[2] Scottish Prison Serv, Publ Protect Unit, Edinburgh, Midlothian, Scotland
[3] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow, Lanark, Scotland
[4] Univ Dundee, Drug Discovery Unit, Sch Life Sci, Dundee, Scotland
[5] Univ Dundee, Leverhulme Res Ctr Forens Sci, Dundee, Scotland
[6] Manchester Metropolitan Univ, Div Chem & Environm Sci, Manchester, Lancs, England
关键词
forensic chemistry; infused papers; new psychoactive substances; prison; synthetic cannabinoid receptor agonists; PHARMACOLOGY; SUBSTANCES; INDAZOLE; FUBINACA; INDOLE; SPICE;
D O I
10.1002/dta.2767
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Drug misuse in prisons contributes to increased disruption and violence and negatively impacts prisoner safety, rehabilitation, and recovery. Synthetic cannabinoid receptor agonists (SCRAs), colloquially known as "spice", are infused into papers and are of particular concern in a prison setting where they are commonly vaped. Methods for the qualitative and quantitative analysis of SCRA infused papers, including impurity profiling, were developed using gas chromatography-mass spectrometry (GC-MS) with qualitative confirmation by ultra high pressure liquid chromatography with photodiode array and quadrupole time of flight mass spectrometry detection (UPLC-PDA-QToF-MS) and applied to 354 individual seized paper samples originating from 168 seizures from three Scottish prisons. Of these samples, 41% (146 samples from 101 seizures) contained at least one SCRA and multiple SCRAs were detected on 23% of these papers. Concentrations ranged from < 0.05-1.17 mg/cm(2) paper, representing the first reported quantitative data for SCRA infused papers. An evolution in the SCRAs detected was demonstrated; 5F-MDMB-PINACA (5F-ADB) predominated until late 2018, after which time 5F-MDMB-PICA and 4F-MDMB-BINACA became increasingly more prevalent, followed by the arrival of MDMB-4en-PINACA in June 2019. Concentration mapping data from two seized paper samples demonstrated that SCRA concentrations across larger papers were highly variable (0.47-2.38 mg/cm(2) paper) making consistent dosing by users, and representative sampling by laboratory analysts, difficult. Near real-time qualitative and quantitative information on SCRAs circulating in prisons acts as an early warning system for SCRAs emerging on the wider illicit market, inform the methods used to detect them and limit supply, and provide information to support harm reduction measures.
引用
收藏
页码:538 / 554
页数:17
相关论文
共 29 条
  • [21] Synthetic cannabinoid receptor agonist (SCRA) detection from pooled urine samples in central London
    Archer, John R. H.
    Hudson, Simon
    Abouchedid, Rachelle
    Ho, James
    Wood, David M.
    Dargan, Paul I.
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 451 - 451
  • [22] Exploiting the triple quadrupole mass analyzer for the open detection and tentative identification of synthetic cannabinoid receptor agonists based on common fragmentation pathways
    Mata-Pesquera, Maria
    Fabregat-Safont, David
    Sancho, Juan, V
    Ibanez, Maria
    ANALYTICA CHIMICA ACTA, 2024, 1329
  • [23] Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists
    Norman, Caitlyn
    Webling, Kristin
    Kyslychenko, Oleksandra
    Reid, Robert
    Krotulski, Alex J.
    Farrell, Ryan
    Deventer, Marie H.
    Liu, Huiling
    Connolly, Matthew J.
    Guillou, Claude
    Vinckier, Inge M. J.
    Logan, Barry K.
    NicDaeid, Niamh
    McKenzie, Craig
    Stove, Christophe P.
    Green, Henrik
    DRUG TESTING AND ANALYSIS, 2024, 16 (09) : 915 - 935
  • [24] Synthetic cannabinoid receptor agonists identified in patients with severe clinical toxicity in England: a report from the Identification Of Novel psychoActive substances (IONA) study
    Hill, Simon L.
    Dunn, Michael
    Dargan, Paul I.
    Wood, David M.
    Tucker, Simon
    Grundlingh, Johann
    Kamour, Ashraf
    Acheampong, Paul
    Thomas, Simon H. L.
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 452 - 452
  • [25] Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples
    Antonides, Lysbeth H.
    Cannaert, Annelies
    Norman, Caitlyn
    Vives, Loelia
    Harrison, Aidan
    Costello, Andrew
    Daeid, Niamh Nic
    Stove, Christophe P.
    Sutcliffe, Oliver B.
    McKenzie, Craig
    FRONTIERS IN CHEMISTRY, 2019, 7
  • [26] Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service
    Waugh, Jennifer
    Najafi, Javad
    Hawkins, Leonard
    Hill, Simon L.
    Eddleston, Michael
    Vale, J. Allister
    Thompson, John P.
    Thomas, Simon H. L.
    CLINICAL TOXICOLOGY, 2016, 54 (06) : 512 - 518
  • [27] Toxicity following recreational use of synthetic cannabinoid receptor agonists and the impact of legal control measures: a report from the UK's National Poisons Information Service
    Najafi, Javad
    Waugh, Jenni
    Hawkins, Leonard
    Hill, Simon L.
    Eddleston, Michael
    Vale, J. Allister
    Thompson, John P.
    Thomas, Simon H. L.
    CLINICAL TOXICOLOGY, 2016, 54 (04) : 386 - 386
  • [28] Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists. A report from the United Kingdom National Poisons Information Service (vol 54, pg 512, 2016)
    Waugh, J.
    Najafi, J.
    Hawkins, L.
    CLINICAL TOXICOLOGY, 2016, 54 (06) : 543 - 543
  • [29] Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances
    Shevyrin, Vadim
    Melkozerov, Vladimir
    Eltsov, Oleg
    Shafran, Yuri
    Morzherin, Yuri
    FORENSIC SCIENCE INTERNATIONAL, 2016, 259 : 95 - 100